LR Health & Beauty Reports 10.9% Q4 Revenue Decline, Full-Year Sales of $326.3 Million

Fourth quarter closes below prior year

LR Health & Beauty has released its financial results for the fourth quarter of 2025, together with preliminary sales and profit data for the full year.

Revenue in the fourth quarter came in at $80.3 million, a decline of 10.9% compared with the same period a year earlier. The company attributed the decrease to subdued consumer sentiment across Western European markets.

EBITDA for the quarter was approximately $353,000. According to the company, the quarterly result was influenced by the lower level of sales as well as extraordinary items connected to the reorganisation of its financing structure.

Full-year figures show softer top and bottom line

For the 2025 financial year as a whole, LR Health & Beauty reported revenue of $326.3 million, representing a year-on-year decline of 4.6%.

Full-year EBITDA stood at $19.4 million, down from $32.1 million in the previous year.

Management points to refinancing and 2026 initiatives

Jörg Körfer, chief executive officer of LR Health & Beauty SE, commented on the results, saying the company is focused on creating the preconditions for sustainably positive business growth.

The company concluded an agreement on the reorganisation of its financing structure, a step it described as a milestone.

For 2026, LR says it intends to develop the business activities of the LR Group through strategic initiatives. One stated focus is the further development of the product portfolio, with the company planning to introduce a new-generation product in the spring that combines its health and beauty expertise.

Forrás: mlmfigyelo.hu. A cikk a forrásban közölt TÉNYEK alapján, a szerkesztőség saját szövegével készült.